At-home STD tests offer new options for screening and treatment
AP News • • health
Key Points:
- The FDA has recently approved the first at-home test detecting gonorrhea, chlamydia, and trichomoniasis in women, as well as a home-based HPV test, expanding convenient options for sexual health screening.
- Two new oral drugs for gonorrhea, Nuzolvenc and Bluejepa, were approved, providing alternatives to the injectable antibiotic ceftriaxone amid rising antibiotic resistance.
- These advancements come as STD rates in the U.S. show a decline for the third consecutive year, attributed to factors like increased at-home testing and changes in sexual behavior.
- While new tests offer faster results and privacy, their higher costs and lack of insurance coverage may limit access, especially for underserved populations, compounded by recent
